News

Filter

Current filters:

Strides ArcolabPfizer

News briefs: Drug majors eyeing Strides Arcolab unit; Astellas invests in oncology facility

20-08-2012

Leading drug multinationals, including global behemoth Pfizer (NYSE: PFE) and Swiss major Novartis (NOVN:…

Agila SpecialitesAstellas PharmaGenericsHospiraMergers & AcquisitionsNovartisPfizerPharmaceuticalProductionStrides Arcolab

Strides Arcolab gets two more cancer generics approved in USA

27-11-2011

Onco Therapies, a wholly owned subsidiary of Indian generics drugmakers Strides Arcolab (BO: 532531),…

CarboplatinGenericsMarkets & MarketingNorth AmericaOnco TherapiesOncologyOxaliplatin InjectionPfizerRegulationStrides Arcolab

Pfizer buys Akorn-Strides portfolio of generics for $63 million

04-01-2011

Facing generic competition itself for its biggest-ever selling drug Lipitor (atorvastatin), global pharma…

Akornakorn-stridesGenericsMergers & AcquisitionsPfizerPharmaceuticalStrides Arcolab

Pfizer signs deals with Indian drugmaker Strides Arcolab for generic cancer drugs and niche injectables

17-05-2010

Further expanding its foot print in the generic drugs market, global drugs behemoth Pfizer is strengthening…

GenericsLicensingOncologyPfizerPharmaceuticalStrides Arcolab

COMPANY SPOTLIGHT

Menarini

Back to top